Mehrdad Ameri

Mehrdad Ameri is the Senior Director and Head of Clinical Pathology at GlaxoSmithKline, a position held since 2018. Prior to this role, they served as the Director and Head of Clinical Pathology at GSK from 2015 to 2018. Mehrdad was the Director of Pathology and Biomarkers at Amgen from 2011 to 2015 and worked as a Senior Pathologist at Pfizer from 2008 to 2011. Their early career includes a Clinical Pathology Residency at Kansas State University from 2004 to 2006 and a role as an Adjunct Instructor and Resident in Diagnostic Immunology at Iowa State University from 2001 to 2004.